Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.

Revenue
+5.52%
EPS
+258.4%
Free cash flow
−7.81%
Total debt
+47.1%

Quarter to September 2026, against a year earlier

334.79 4.89 −1.44%
Market cap
$64.8B
P/E
18.8×
Fwd P/E
17.5×
Dividend yield
0.71%
F-score
7/9
Altman Z
n/a
Beneish M
−2.59
Dividend safety
70/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
16.64 20.93 23.94 40.30

+8 more quarters

P/S ratio
0.17 0.16 0.19 0.20
P/FCF ratio
14.76 13.31 38.15 17.97
P/Operating CF
18.47 20.59 45.65 (28.46)
P/B ratio
17.69 16.87 17.05 31.30
EV/Sales
0.19 0.19 0.22 0.22
EV/EBITDA
15.49 15.46 18.58 19.22
EV/FCF
16.41 15.48 44.52 19.66
Current Ratio
0.94 0.93 0.95 0.92
Net Debt/EBITDA
0.00 6.37 7.26 6.02
Debt/Equity
3.06 3.62 3.45 3.78
Earnings Yield
6.01% 4.78% 4.18% 2.48%
Free Cash Flow Yield
6.77% 7.51% 2.62% 5.56%
Free Cash Flow per Share
13.93 12.58 6.03 (12.26)
Book value per Share
19.29 16.77 18.43 10.79
Free Cash Flow
2,658.35 2,430.06 1,173.74 (2,381.49)
EV/EBIT
16.20 20.90 25.57 26.75
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026